After cardiac surgery with cardiopulmonary bypass (CPB), acquired coagulopathy often leads to post-CPB bleeding. Though multifactorial in origin, this coagulopathy is often aggravated by deficient fibrinogen levels.To assess whether laboratory and thrombelastometric testing on CPB can predict plasma fibrinogen immediately after CPB weaning.This prospective study in 110 patients undergoing major cardiovascular surgery at risk of post-CPB bleeding compares fibrinogen level (Clauss method) and function (fibrin-specific thrombelastometry) in order to study the predictability of their course early after termination of CPB. Linear regression analysis and receiver operating characteristics were used to determine correlations and predictive accurac...
Background: Bleeding after cardiopulmonary bypass (CPB) is a major cause of morbidity and mortality ...
Background: Bleeding after cardiopulmonary bypass (CPB) is a major cause of morbidity and mortality ...
Background: Fibrinogen is the main biomarker for bleeding. To prevent excessive postoperative bleedi...
After cardiac surgery with cardiopulmonary bypass (CPB), acquired coagulopathy often leads to post-C...
BACKGROUND After cardiac surgery with cardiopulmonary bypass (CPB), acquired coagulopathy often l...
Background After cardiac surgery with cardiopulmonary bypass (CPB), acquired coagulopathy often lead...
BACKGROUND: After cardiac surgery with cardiopulmonary bypass (CPB), acquired coagulopathy often lea...
BACKGROUND: After cardiac surgery with cardiopulmonary bypass (CPB), acquired coagulopathy often lea...
Plasma fibrinogen concentration is important for coagulopathy assessment, and is most commonly measu...
Low plasma fibrinogen level is common after cardiopulmonary bypass (CPB). Current substitution pract...
Plasma fibrinogen concentration is important for coagulopathy assessment, and is most commonly measu...
BackgroundFibrinogen, the major clotting protein in blood plasma, plays key roles in blood coagulati...
Maintenance of adequate fibrinogen levels during cardiopulmonary bypass (CPB) is important in assuri...
Maintenance of adequate fibrinogen levels during cardiopulmonary bypass (CPB) is important in assuri...
Background: Bleeding after cardiopulmonary bypass (CPB) is a major cause of morbidity and mortality ...
Background: Bleeding after cardiopulmonary bypass (CPB) is a major cause of morbidity and mortality ...
Background: Bleeding after cardiopulmonary bypass (CPB) is a major cause of morbidity and mortality ...
Background: Fibrinogen is the main biomarker for bleeding. To prevent excessive postoperative bleedi...
After cardiac surgery with cardiopulmonary bypass (CPB), acquired coagulopathy often leads to post-C...
BACKGROUND After cardiac surgery with cardiopulmonary bypass (CPB), acquired coagulopathy often l...
Background After cardiac surgery with cardiopulmonary bypass (CPB), acquired coagulopathy often lead...
BACKGROUND: After cardiac surgery with cardiopulmonary bypass (CPB), acquired coagulopathy often lea...
BACKGROUND: After cardiac surgery with cardiopulmonary bypass (CPB), acquired coagulopathy often lea...
Plasma fibrinogen concentration is important for coagulopathy assessment, and is most commonly measu...
Low plasma fibrinogen level is common after cardiopulmonary bypass (CPB). Current substitution pract...
Plasma fibrinogen concentration is important for coagulopathy assessment, and is most commonly measu...
BackgroundFibrinogen, the major clotting protein in blood plasma, plays key roles in blood coagulati...
Maintenance of adequate fibrinogen levels during cardiopulmonary bypass (CPB) is important in assuri...
Maintenance of adequate fibrinogen levels during cardiopulmonary bypass (CPB) is important in assuri...
Background: Bleeding after cardiopulmonary bypass (CPB) is a major cause of morbidity and mortality ...
Background: Bleeding after cardiopulmonary bypass (CPB) is a major cause of morbidity and mortality ...
Background: Bleeding after cardiopulmonary bypass (CPB) is a major cause of morbidity and mortality ...
Background: Fibrinogen is the main biomarker for bleeding. To prevent excessive postoperative bleedi...